Entrada Therapeutics (TRDA) Q3 2025 Earnings

6AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-1.04
-0.68
-0.33
0.03

Details

Expected EPS
-0.8472
Actual EPS
-1.04
Surprise EPS
-0.19
Surprise Percent
+22.76%

Description

Entrada Therapeutics (TRDA) has reported earnings of -1.04 per share for Q3 2025.

0 Comments

Share your thoughts